From Conventional to Nano‐Enabled Combination Therapies to Address Therapeutic Challenges of Malaria
Drug Development Research · 2026-11 · 87 (7)
DOI: 10.1002/ddr.70395 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 28.10.2026. Verfasst von Maha Mohammad Eissa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Antimalarials, Malaria. Die Arbeit nennt 165 Literaturangaben.
Abstract (Originalsprache)
Malaria, a poverty‐related disease, is a significant global health burden. Combination therapy is one of the most efficient approaches currently used to treat malaria infections, with artemisinin‐based combination therapies being the recommended first‐line treatment. Nevertheless, the emergence of resistance to artemisinin and its derivatives underscores the importance of developing new alternative antimalarial combinations as well as innovative therapeutic strategies to combat the disease. Intersecting combination therapy with nanotechnology could create innovative and highly effective nano‐based combination therapies. This approach has shown notable benefits in treating various diseases, particularly cancer, and holds great potential in infectious disease treatment. Initial preclinical studies have demonstrated the potential of nano‐based combination therapies in malaria treatment. This narrative review provides a panoramic overview of regulatory‐approved and internationally endorsed conventional combination therapies for malaria and explores ongoing research into developing novel conventional and nano‐based combination therapies. It aims to guide future research funding, inspires the development of innovative next‐generation nano‐based combination therapies, and supports their clinical translation, thereby maximizing efforts to fight malaria and accelerating disease elimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Department of Medical Parasitology, Faculty of Medicine, Sohag University, Sohag, Egypt.
ORCID-Profile: Maha Mohammad Eissa, Eman Fathi Fadel
Zitieren
APA
Eissa, M. M., & Fadel, E. F. (2026). From Conventional to Nano‐Enabled Combination Therapies to Address Therapeutic Challenges of Malaria. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70395
Vancouver
Eissa MM, Fadel EF. From Conventional to Nano‐Enabled Combination Therapies to Address Therapeutic Challenges of Malaria. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70395
BibTeX
@article{Eissa2026,
author = {Eissa, Maha Mohammad and Fadel, Eman Fathi},
title = {From Conventional to Nano‐Enabled Combination Therapies to Address Therapeutic Challenges of Malaria},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {7},
doi = {10.1002/ddr.70395}
}
EUVIMED